These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11841384)
1. A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion. Knudsen H; Grønbaek K; thor Straten P; Gisselø C; Johansen P; Timshel S; Bergmann OJ; Hansen NE; Ralfkiaer E Br J Dermatol; 2002 Jan; 146(1):148-53. PubMed ID: 11841384 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
3. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies. Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295 [TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Williams NS; Kubota A; Bennett M; Kumar V; Takei F Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897 [TBL] [Abstract][Full Text] [Related]
5. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637 [TBL] [Abstract][Full Text] [Related]
6. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes. Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085 [TBL] [Abstract][Full Text] [Related]
7. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417 [TBL] [Abstract][Full Text] [Related]
8. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212 [TBL] [Abstract][Full Text] [Related]
9. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449 [TBL] [Abstract][Full Text] [Related]
10. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682 [TBL] [Abstract][Full Text] [Related]
11. Two genes in the rat homologous to human NKG2. Berg SF; Dissen E; Westgaard IH; Fossum S Eur J Immunol; 1998 Feb; 28(2):444-50. PubMed ID: 9521051 [TBL] [Abstract][Full Text] [Related]
12. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman. Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287 [TBL] [Abstract][Full Text] [Related]
13. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma. Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475 [TBL] [Abstract][Full Text] [Related]
14. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features. Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525 [TBL] [Abstract][Full Text] [Related]
15. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Vance RE; Tanamachi DM; Hanke T; Raulet DH Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811 [TBL] [Abstract][Full Text] [Related]
16. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas]. Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963 [TBL] [Abstract][Full Text] [Related]
19. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression. Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738 [TBL] [Abstract][Full Text] [Related]
20. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]